Tech Films Reports Audited Financial Results for Quarter and...
Source: scanx.trade
Gokaldas Exports has allotted 26,400 equity shares of Rs. 5/- each on May 07, 2026, following the exercise of stock options by eligible employees. The allotment was carried out by the Nomination and Remuneration Committee of the company in compliance with Regulation 30 read with Schedule III Part A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
ESOP Allotment Breakdown
The 26,400 equity shares were allotted under two distinct employee stock option schemes. The following table summarises the scheme-wise distribution:
Scheme: Shares Allotted Employee Stock Option Scheme 2010 23,000 equity shares GEL Employee Stock Option Plan 2022 3,400 equity shares Total 26,400 equity shares
Impact on Paid-Up Share Capital
Effective May 07, 2026, the allotment has resulted in an increase in the paid-up share capital of Gokaldas Exports. The table below captures the change in share capital following the allotment:
Parameter: Before Allotment After Allotment Paid-Up Share Capital Rs. 36,62,36,140 Rs. 36,63,68,140 Number of Equity Shares 7,32,47,228 7,32,73,628 Face Value per Share Rs. 5/- Rs. 5/-
The disclosure was made by Gourish Hegde, Company Secretary & Compliance Officer of Gokaldas Exports, and filed with both BSE Limited and the National Stock Exchange of India Limited on May 07, 2026.
Clear Wealth Consultancy Services LLP has submitted a declaration to BSE Limited and National Stock Exchange of India Limited confirming that no share encumbrance has been made by the promoters of Gokaldas Exports during the financial year ended March 31, 2026. The declaration was made pursuant to Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Declaration Details
The promoters confirmed that members of the promoter and promoter group, including persons acting in concert, have not made any encumbrance of shares, directly or indirectly, during the specified financial year other than those that have been previously disclosed. The declaration was submitted on April 01, 2026.
Key Information
Particulars Details Promoter Entity Clear Wealth Consultancy Services LLP Target Company Gokaldas Exports Limited Financial Year FY26 (ended March 31, 2026) Regulation Regulation 31(4) of SEBI Takeover Regulations, 2011 Declaration Date April 01, 2026
The declaration has been addressed to the Corporate Relationship Department of BSE Limited and the appropriate department at the National Stock Exchange of India Limited. A copy of the declaration has been forwarded to the Audit Committee of Gokaldas Exports Limited.
We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.
Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.
We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.
Disclaimer:
The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.
This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.
The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.
We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.
This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.
By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.
We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.
Source: scanx.trade